BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 27390161)

  • 21. p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging.
    Perk LR; Vosjan MJ; Visser GW; Budde M; Jurek P; Kiefer GE; van Dongen GA
    Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):250-9. PubMed ID: 19763566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation,
    Barta P; Kamaraj R; Kucharova M; Novy Z; Petrik M; Bendova K; Hajduch M; Pavek P; Trejtnar F
    Bioconjug Chem; 2022 Oct; 33(10):1825-1836. PubMed ID: 36197842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. scVEGF microbubble ultrasound contrast agents: a novel probe for ultrasound molecular imaging of tumor angiogenesis.
    Anderson CR; Rychak JJ; Backer M; Backer J; Ley K; Klibanov AL
    Invest Radiol; 2010 Oct; 45(10):579-85. PubMed ID: 20733505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab.
    Perk LR; Visser GW; Vosjan MJ; Stigter-van Walsum M; Tijink BM; Leemans CR; van Dongen GA
    J Nucl Med; 2005 Nov; 46(11):1898-906. PubMed ID: 16269605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical Pharmacokinetics and Biodistribution Studies of 89Zr-Labeled Pembrolizumab.
    England CG; Ehlerding EB; Hernandez R; Rekoske BT; Graves SA; Sun H; Liu G; McNeel DG; Barnhart TE; Cai W
    J Nucl Med; 2017 Jan; 58(1):162-168. PubMed ID: 27493273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.
    Verel I; Visser GW; Boellaard R; Boerman OC; van Eerd J; Snow GB; Lammertsma AA; van Dongen GA
    J Nucl Med; 2003 Oct; 44(10):1663-70. PubMed ID: 14530484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging vascular endothelial growth factor (VEGF) receptors in turpentine-induced sterile thigh abscesses with radiolabeled single-chain VEGF.
    Levashova Z; Backer M; Backer JM; Blankenberg FG
    J Nucl Med; 2009 Dec; 50(12):2058-63. PubMed ID: 19910439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of tumor VEGF-A levels with 89Zr-bevacizumab PET as an early biomarker for the antiangiogenic effect of everolimus treatment in an ovarian cancer xenograft model.
    van der Bilt AR; Terwisscha van Scheltinga AG; Timmer-Bosscha H; Schröder CP; Pot L; Kosterink JG; van der Zee AG; Lub-de Hooge MN; de Jong S; de Vries EG; Reyners AK
    Clin Cancer Res; 2012 Nov; 18(22):6306-14. PubMed ID: 23014526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor imaging using a standardized radiolabeled adapter protein docked to vascular endothelial growth factor.
    Blankenberg FG; Mandl S; Cao YA; O'Connell-Rodwell C; Contag C; Mari C; Gaynutdinov TI; Vanderheyden JL; Backer MV; Backer JM
    J Nucl Med; 2004 Aug; 45(8):1373-80. PubMed ID: 15299064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immuno-PET Imaging of CD30-Positive Lymphoma Using 89Zr-Desferrioxamine-Labeled CD30-Specific AC-10 Antibody.
    Rylova SN; Del Pozzo L; Klingeberg C; Tönnesmann R; Illert AL; Meyer PT; Maecke HR; Holland JP
    J Nucl Med; 2016 Jan; 57(1):96-102. PubMed ID: 26514172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ImmunoPET imaging of tissue factor expression in pancreatic cancer with
    Hernandez R; England CG; Yang Y; Valdovinos HF; Liu B; Wong HC; Barnhart TE; Cai W
    J Control Release; 2017 Oct; 264():160-168. PubMed ID: 28843831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging VEGF Receptors and α
    Tekabe Y; Li Q; Zhang G; Johnson J; Schmidt AM; Backer M; Backer J; Johnson LL
    Mol Imaging Biol; 2018 Dec; 20(6):963-972. PubMed ID: 29687324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct site-specific labeling of the Cys-tag moiety in scVEGF with technetium 99m.
    Levashova Z; Backer M; Backer JM; Blankenberg FG
    Bioconjug Chem; 2008 May; 19(5):1049-54. PubMed ID: 18407683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein Nanoparticles.
    Pérez-Medina C; Tang J; Abdel-Atti D; Hogstad B; Merad M; Fisher EA; Fayad ZA; Lewis JS; Mulder WJ; Reiner T
    J Nucl Med; 2015 Aug; 56(8):1272-7. PubMed ID: 26112022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The development of [(124)I]iodinated-VG76e: a novel tracer for imaging vascular endothelial growth factor in vivo using positron emission tomography.
    Collingridge DR; Carroll VA; Glaser M; Aboagye EO; Osman S; Hutchinson OC; Barthel H; Luthra SK; Brady F; Bicknell R; Price P; Harris AL
    Cancer Res; 2002 Oct; 62(20):5912-9. PubMed ID: 12384557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trimeric Radiofluorinated Sulfonamide Derivatives to Achieve In Vivo Selectivity for Carbonic Anhydrase IX-Targeted PET Imaging.
    Lau J; Liu Z; Lin KS; Pan J; Zhang Z; Vullo D; Supuran CT; Perrin DM; Bénard F
    J Nucl Med; 2015 Sep; 56(9):1434-40. PubMed ID: 26205302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular imaging of T cell co-regulator factor B7-H3 with
    Burvenich IJG; Parakh S; Lee FT; Guo N; Liu Z; Gan HK; Rigopoulos A; O'Keefe GJ; Gong SJ; Goh YW; Tochon-Danguy H; Scott FE; Kotsuma M; Hirotani K; Senaldi G; Scott AM
    Theranostics; 2018; 8(15):4199-4209. PubMed ID: 30128047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo visualization of MET tumor expression and anticalin biodistribution with the MET-specific anticalin 89Zr-PRS-110 PET tracer.
    Terwisscha van Scheltinga AG; Lub-de Hooge MN; Hinner MJ; Verheijen RB; Allersdorfer A; Hülsmeyer M; Nagengast WB; Schröder CP; Kosterink JG; de Vries EG; Audoly L; Olwill SA
    J Nucl Med; 2014 Apr; 55(4):665-71. PubMed ID: 24614223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bevacizumab Targeting Diffuse Intrinsic Pontine Glioma: Results of 89Zr-Bevacizumab PET Imaging in Brain Tumor Models.
    Jansen MH; Lagerweij T; Sewing AC; Vugts DJ; van Vuurden DG; Molthoff CF; Caretti V; Veringa SJ; Petersen N; Carcaboso AM; Noske DP; Vandertop WP; Wesseling P; van Dongen GA; Kaspers GJ; Hulleman E
    Mol Cancer Ther; 2016 Sep; 15(9):2166-74. PubMed ID: 27325687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Theranostic role of
    Yang Q; Chen Z; Qiu Y; Huang W; Wang T; Song L; Sun X; Li C; Xu X; Kang L
    Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1246-1260. PubMed ID: 38135849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.